Kovai Medical Center and Hospital Limited (NSE:KOVAI)
6,062.50
-29.00 (-0.48%)
Sep 4, 2026, 3:29 PM IST
NSE:KOVAI Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 66,239 | 54,959 | 56,686 | 40,944 | 20,143 | 17,458 | |
Market Cap Growth | -4.66% | -3.05% | 38.45% | 103.27% | 15.38% | 44.69% |
Enterprise Value | 66,818 | 55,866 | 58,345 | 43,052 | 23,137 | 21,327 |
Last Close Price | 6062.50 | 2550.31 | 2550.31 | 2550.31 | 1820.34 | 1563.24 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 25.84 | 22.48 | 27.13 | 22.78 | 17.40 | 16.74 |
PS Ratio | 4.03 | 3.47 | 4.13 | 3.36 | 1.98 | 1.93 |
PB Ratio | 5.02 | 4.17 | 5.22 | 4.61 | 2.80 | 2.87 |
P/TBV Ratio | 5.05 | 4.19 | 5.26 | 4.62 | 2.81 | 2.88 |
P/FCF Ratio | 60.28 | 50.02 | - | 19.90 | 14.86 | 10.74 |
P/OCF Ratio | 18.31 | 15.19 | 16.94 | 11.90 | 7.66 | 6.67 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 4.07 | 3.52 | 4.26 | 3.53 | 2.27 | 2.36 |
EV/EBITDA Ratio | 14.64 | 12.77 | 15.29 | 12.77 | 8.70 | 8.41 |
EV/EBIT Ratio | 19.27 | 16.71 | 20.19 | 17.23 | 12.74 | 12.37 |
EV/FCF Ratio | 60.81 | 50.84 | - | 20.93 | 17.07 | 13.12 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.31 | 0.31 | 0.38 | 0.35 | 0.71 | 0.90 |
Debt / EBITDA Ratio | 0.88 | 0.91 | 1.08 | 0.91 | 1.90 | 2.14 |
Debt / FCF Ratio | - | 3.67 | - | 1.51 | 3.77 | 3.39 |
Net Debt / Equity Ratio | 0.04 | 0.04 | 0.13 | 0.12 | 0.37 | 0.58 |
Net Debt / EBITDA Ratio | 0.13 | 0.13 | 0.38 | 0.30 | 0.99 | 1.40 |
Net Debt / FCF Ratio | - | 0.53 | -7.79 | 0.50 | 1.95 | 2.18 |
Asset Turnover | - | 0.82 | 0.85 | 0.85 | 0.73 | 0.69 |
Inventory Turnover | - | 45.90 | 46.67 | 41.99 | 38.48 | 38.99 |
Quick Ratio | - | 1.19 | 1.13 | 1.12 | 1.51 | 1.35 |
Current Ratio | - | 1.29 | 1.23 | 1.23 | 1.63 | 1.46 |
Return on Equity (ROE) | - | 20.33% | 21.16% | 22.36% | 17.43% | 18.63% |
Return on Assets (ROA) | - | 10.81% | 11.16% | 10.86% | 8.16% | 8.21% |
Return on Invested Capital (ROIC) | 18.93% | 19.25% | 19.59% | 19.15% | 13.91% | 13.14% |
Return on Capital Employed (ROCE) | - | 19.20% | 18.90% | 20.20% | 14.40% | 14.60% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 3.87% | 4.45% | 3.69% | 4.39% | 5.75% | 5.97% |
FCF Yield | 1.66% | 2.00% | -0.33% | 5.02% | 6.73% | 9.31% |
Dividend Yield | 0.25% | 0.59% | 0.39% | 0.39% | 0.27% | 0.19% |
Payout Ratio | - | 4.46% | 5.14% | 6.07% | 2.84% | 3.15% |
Total Shareholder Return | 0.24% | 0.59% | 0.39% | 0.39% | 0.27% | 0.19% |